Kala Bio Inc [KALA] stock is trading at $7.0, up 23.89%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KALA shares have gain 17.25% over the last week, with a monthly amount glided 75.00%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kala Bio Inc [NASDAQ: KALA] stock has seen the most recent analyst activity on July 11, 2025, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $12. Previously, JP Morgan downgraded its rating to Underweight on March 30, 2022. On August 06, 2021, downgrade downgraded it’s rating to Neutral. Jefferies downgraded its rating to a Hold but stick to its price target of $10 on September 14, 2020. Northland Capital initiated its recommendation with a Outperform. In a note dated May 27, 2020, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $14 to $17.
Kala Bio Inc [KALA] stock has fluctuated between $2.92 and $11.20 over the past year. Currently, Wall Street analysts expect the stock to reach $7.5 within the next 12 months. Kala Bio Inc [NASDAQ: KALA] shares were valued at $7.0 at the most recent close of the market. An investor can expect a potential return of 7.14% based on the average KALA price forecast.
Analyzing the KALA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.74, Equity is -3.69 and Total Capital is -1.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.08 points at the first support level, and at 5.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.51, and for the 2nd resistance point, it is at 8.02.
Ratios To Look Out For
For context, Kala Bio Inc’s Current Ratio is 1.99. As well, the Quick Ratio is 1.99, while the Cash Ratio is 1.84.
Transactions by insiders
Recent insider trading involved Kharabi Darius, CHIEF BUSINESS OFFICER, that happened on Jun 24 ’25 when 4511.0 shares were sold. CHIEF FINANCIAL OFFICER, Reumuth Mary completed a deal on Jun 24 ’25 to sell 3631.0 shares. Meanwhile, Bazemore Todd sold 4058.0 shares on Jun 24 ’25.
